Encompass Health Corporation (EHC) Tops Q2 EPS by 7c; raises guidance

Encompass Health Corporation (NYSE: EHC) reported Q2 EPS of $1.55, $0.07 better than the analyst estimate of $1.48. Revenue for the quarter came in at $1.6 billion versus the consensus estimate of $1.57 billion.

GUIDANCE:

Encompass Health Corporation sees FY2026 EPS of $6.02-$6.25, versus the consensus of $6.00. Encompass Health Corporation sees FY2026 revenue of $6.41-6.49 billion, versus the consensus of $6.42 billion.

For earnings history and earnings-related data on Encompass Health Corporation (EHC) click here.

You May Also Be Interested In

• Campbell Soup (CPB) Reports In-Line Q4 EPS, Misses on Revenue; Offers FY27 EPS Guidance
• Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance
• Macquarie Upgrades Broadcom Limited (AVGO) to Outperform